THE MOBILE GUIDE



The Mobile Guide
Trends, data, insights and expert advice on the challenges and opportunities of using mobile to reach healthcare professionals and consumers

WEBCAST


Why is Regional Marketing So Hot?

Audience will learn how regional marketing can benefit your brand's position; how to make regional marketing simple and executable; and the value of a district level driver analysis and how this can become the foundation of regional marketing intelligence.

Sponsored by:

White Papers

SUBSCRIBE TO MM&M


MM&M 
offers the most relevant news, analysis, opinion, feature stories and special reports to nearly 15,000 marketing executives at pharma companies, agencies and in healthcare media. Click here to subscribe.

THE INTERACTIVE GUIDE


Click here to read the MM&M 2013 Mobile Guide, with the latest trends, data, insights and expert advice on the challenges and opportunities of using mobile to reach healthcare professionals and consumers

2010/11 PMD


NOW FULLY
SEARCHABLE ONLINE
UPDATED MONTHLY @ ThePMD.com
Over 6,000 new names, and 20,000 business connections. From the industry's trusted resource for over 34 years. Now find what you need even quicker and easier with the searchable online edition.

Get connected today and order your personal copy and free online access!

The MM&M News Brief provides news and features delivered direct to your inbox. To access the full text, simply click the headline.

Latest News

FDA to IOM: More work? No thanks

The FDA is moving cautiously on a call by the Institute of Medicine to scrap the approvals process for many medical devices.
 

Recent Pfizer CME grants take non-clinical approach

In a sign of industry's ongoing desire to broaden its CME funding outlook, a couple of recently supported educational programs by Pfizer aim to foster practice-based improvement as they seek to advance the science of CME.
 



Why is Regional Marketing So Hot? Audience will learn how regional marketing can benefit your brand's position; how to make regional marketing simple and executable; and the value of a district level driver analysis and how this can become the foundation of regional marketing intelligence.

In Brief

Company news: Amylin, Eli Lilly, Alkermes, Gilead and J&J

Amylin, Eli Lilly and Alkermes said the FDA accepted their Bydureon resubmission and awarded a six-month review, extending the PDUFA date to January 28, 2012.
 

LATEST FEATURES

Global Report: Mobile Conquest

Outside the US, bespoke tools and resources that doctors can use at the point of care through a mobile device are still somewhat rare. An app from Novo Nordisk fills that niche while threading the regulatory needle overseas
 

Therapeutic Focus: Infectious Diseases

Newly launched products break ground in clearing life-threatening viruses and stanching stubborn infections. But that's only half the battle
 

Search Parties

Does the battle for social supremacy being waged by Google, Facebook and Bing make this medium more or less viable for pharma marketers?
 

Managed Markets: Meet Formulary Fred...

Fred's a really nice managed care guy. But does he have the right stuff to get your brand the preferred nod? Kevin McDermott explains how to make sure
 

Headliner: Pfizer's Sally Susman

Big is not necessarily bad, says Pfizer PR supremo Sally Susman. "Big can be a force for good."
 




Advertise
For details on how to advertise in MM&M News Brief, please email Doreen Gates

Unsubscribe
To unsubscribe from the MM&M News Brief click here.
To manage your entire MM&M profile login to your account.

You are subscribed as: %%EMAIL%%

To contact Haymarket Media for general questions or unsubscribe problems, please reply to this email.

All MM&M newsletters are sent from the domain "email.mmm-online.com". When configuring e-mail or spam
filter rules, please use this domain name.

Medical Marketing & Media Magazine
114 W. 26th Street 4th Floor
New York N.Y. 10001
Phone: (646) 638-6000
Fax: (646) 638-6150
http://www.mmm-online.com/

© 2013 Haymarket Media Inc.